Fraction Effective Dose Calculator (Radiotherapy BED and EQD2)
Estimate fraction effective dose, Biologically Effective Dose (BED), and Equivalent Dose in 2 Gy fractions (EQD2) using the linear-quadratic model.
How to Calculate Fraction Effective Dose: A Complete Expert Guide
If you are trying to understand how to calculate fraction effective dose in radiation oncology, you are usually asking a highly practical question: how do we compare one fractionation schedule against another in terms of biological effect, not just physical dose? In modern radiotherapy, physical dose in Gy is only part of the story. The way that dose is split into fractions can significantly change tumor control and normal tissue toxicity.
The most common way to account for this is the linear-quadratic (LQ) model, which gives us two essential quantities:
- BED (Biologically Effective Dose)
- EQD2 (Equivalent Dose in 2 Gy fractions)
This page calculator helps you compute all three practical outputs clinicians and planners discuss:
- Physical dose per fraction (d = D/n)
- Fraction effective dose contribution per fraction
- Total BED and EQD2 for schedule comparison
Why fraction effective dose matters clinically
Fractionation is central in radiation oncology because tissues respond differently to dose size per fraction. Small changes in dose per fraction can have large downstream biological consequences, especially for organs at risk with low alpha-beta values. That is why two schedules with similar total Gy can behave very differently in practice.
For example, 60 Gy in 30 fractions (2.0 Gy/fraction) and 55 Gy in 20 fractions (2.75 Gy/fraction) are not biologically equal for every tissue type. BED and EQD2 provide a structured way to compare these regimens.
The core formulas
Let:
- D = total dose (Gy)
- n = number of fractions
- d = dose per fraction = D/n
- alpha-beta = tissue-specific parameter (Gy)
Then:
- BED = n × d × (1 + d / alpha-beta)
- EQD2 = BED / (1 + 2 / alpha-beta)
- Fraction effective dose per fraction = d × (1 + d / alpha-beta)
The third metric is useful when people informally refer to “fraction effective dose.” It represents the biological contribution of each fraction under the LQ assumption.
Step-by-step worked example
Suppose your schedule is 60 Gy in 30 fractions, and you are evaluating tumor effect with alpha-beta = 10 Gy.
- Calculate dose per fraction: d = 60 / 30 = 2 Gy
- Fraction effective dose per fraction: 2 × (1 + 2/10) = 2 × 1.2 = 2.4
- BED: 30 × 2.4 = 72 Gy10
- EQD2: 72 / (1 + 2/10) = 72 / 1.2 = 60 Gy
Now use alpha-beta = 3 Gy for late normal tissue:
- d = 2 Gy
- Fraction effective contribution: 2 × (1 + 2/3) = 3.33
- BED: 30 × 3.33 = 100 Gy3 (rounded)
- EQD2: 100 / (1 + 2/3) = 60 Gy
Notice how EQD2 for this exact 2 Gy fractionation returns the same physical dose (60 Gy), while BED changes based on alpha-beta assumptions.
Common alpha-beta choices and interpretation
- 10 Gy: often used for many tumors and early responding tissues.
- 3 Gy: often used for late responding normal tissue risk assessment.
- 1 to 2 Gy: often discussed for prostate and some slowly proliferating tissues.
The lower the alpha-beta, the more sensitive the tissue is to changes in fraction size. That is exactly why hypofractionation can create larger biological shifts for low alpha-beta systems.
Comparison Table 1: Fractionation schedules and modeled BED/EQD2
The table below shows mathematically derived comparisons using standard LQ equations. Values are rounded and shown for both alpha-beta 10 and alpha-beta 3.
| Schedule | Dose per Fraction (Gy) | BED (alpha-beta 10) | EQD2 (alpha-beta 10) | BED (alpha-beta 3) | EQD2 (alpha-beta 3) |
|---|---|---|---|---|---|
| 60 Gy / 30 fx | 2.00 | 72.0 | 60.0 | 100.0 | 60.0 |
| 55 Gy / 20 fx | 2.75 | 70.1 | 58.4 | 105.4 | 63.2 |
| 40 Gy / 15 fx | 2.67 | 50.7 | 42.2 | 75.6 | 45.4 |
| 26 Gy / 5 fx | 5.20 | 39.5 | 32.9 | 71.1 | 42.7 |
| 70 Gy / 35 fx | 2.00 | 84.0 | 70.0 | 116.7 | 70.0 |
How trial outcomes connect to fraction effective dose logic
Clinical trial data support the practical importance of dose-per-fraction biology. While outcomes depend on many factors including technique, target delineation, systemic therapy, and patient selection, LQ-based calculations help frame why schedules can be non-inferior or produce different toxicity profiles.
| Trial Context | Compared Schedules | Reported Outcome Snapshot | Why FED/BED Matters |
|---|---|---|---|
| START-B (Breast) | 40 Gy/15 fx vs 50 Gy/25 fx | 10-year local-regional relapse roughly 4.3% vs 5.5% | Moderate hypofractionation can maintain control with acceptable normal tissue effects. |
| FAST-Forward (Breast) | 26 Gy/5 fx vs 40 Gy/15 fx | 5-year ipsilateral breast tumor relapse around 2.1% vs 1.7% | Large fraction size requires careful BED interpretation for tumor and normal tissue balance. |
| CHHiP (Prostate) | 60 Gy/20 fx vs 74 Gy/37 fx | 5-year biochemical or clinical control non-inferiority demonstrated | Low alpha-beta assumptions support hypofractionation rationale in prostate treatment. |
Best practices when using a fraction effective dose calculator
1. Keep units consistent
If your treatment planning system exports in cGy, convert to Gy before applying LQ formulas (100 cGy = 1 Gy). This calculator can accept either input unit and converts internally.
2. Use clinically appropriate alpha-beta assumptions
Do not rely on one alpha-beta value for every question. Many teams check at least two scenarios:
- Tumor-centered estimate (often alpha-beta near 10 for many disease sites)
- Late-toxicity-centered estimate (often alpha-beta around 3)
For disease sites like prostate, low alpha-beta assumptions are often explored to evaluate hypofractionated schedules.
3. Remember model boundaries
The LQ model is a standard tool, but every model has assumptions. At very high dose per fraction, interpretation should be cautious and anchored in clinical evidence, protocol design, and departmental policy.
4. Compare plans, not isolated numbers
BED and EQD2 are decision-support metrics. They do not replace DVH review, organ constraints, image guidance quality, motion management, setup reproducibility, and physician judgment.
Practical workflow for planners and clinicians
- Enter total dose and fraction number.
- Select dose units (Gy or cGy).
- Choose tissue preset or custom alpha-beta.
- Calculate dose per fraction, BED, and EQD2.
- Document assumptions used (especially alpha-beta value).
- Cross-check against institutional protocol and trial-based constraints.
Frequently asked questions
Is fraction effective dose the same as BED?
Not exactly. BED is the total biological effect across all fractions. Fraction effective dose is commonly used informally to describe the biological contribution of each fraction, which sums to BED.
Why do two schedules with similar total Gy behave differently?
Because biological effect depends on fraction size. Larger dose per fraction increases the quadratic injury component in the LQ model, shifting tumor and normal tissue effects.
Should I use EQD2 or BED for reporting?
Both are useful. BED is direct from the model and convenient for biology-based comparisons. EQD2 is often easier for communication because it maps to the familiar 2 Gy fraction standard.
Key statistics and context for radiation use
Radiation oncology is a major treatment pillar. Public cancer resources consistently report high use of radiation in the overall cancer population and emphasize multimodality treatment planning. Large randomized trials have established that properly selected hypofractionated schedules can achieve outcomes comparable to conventional fractionation in multiple disease settings.
If you are learning how to calculate fraction effective dose, the practical takeaway is this: use the formula, but always place the number inside clinical context, evidence quality, and protocol constraints.
Final reminder: this calculator is for education and planning support. It is not a substitute for medical advice, physician prescription, or institutional treatment protocol approval.